Posted on 6/11/20
Here's Why The Clouds Have Lifted For Quest Diagnostics
After hitting its 52-week low in April, Quest Diagnostics (NYSE:DGX) has seen its stock recover nicely, even beating the S&P 500 year to date. This diagnostic . . .
Posted on 4/10/20
Here's Why Regeneron’s Stock Is Worth More Than Its Coronavirus Work
Regeneron's (NASDAQ:REGN) stock has increased by 34% in 2020 as the company and its partner Sanofi (NASDAQ:SNY) initiated two large scale phase 2/3 clinical trials in . . .
Philadelphia
